CHLORHEXIDINE

Ukraine

The drug is used for the prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis), as well as for the treatment of bacterial vaginosis, colpitis, and cervical erosion. It is also used for the prevention of infections in obstetrics and gynecology before surgeries, childbirth, abortion, or the insertion of an intrauterine device.

Brand name CHLORHEXIDINE
Dosage form tablets, effervescent
Active substance / Dosage
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/17204/01/01
Manufacturer Farmex Group LLC
CHLORHEXIDINE tablets, effervescent

Frequently asked questions

How should Chlorhexidine be taken correctly?

Pessaries are administered intravaginally. For treatment, 1 pessary is typically used 2 times a day for 7–10 days (possible extension up to 20 days). For the prevention of sexually transmitted diseases, it is applied as a single dose — 1 pessary no later than 2 hours after sexual intercourse.

What side effects can Chlorhexidine cause?

Allergic reactions are possible, as well as sensations of itching, burning, or irritation at the site of administration.

Who should not use this drug?

Use is contraindicated in cases of individual hypersensitivity to the components of the product.

Can the drug be used during pregnancy or breastfeeding?

Yes, use during pregnancy and breastfeeding is not contraindicated. During pregnancy, the dosage is determined depending on the infectious process and the presence of a threat of miscarriage.

With which substances should the drug not be combined?

Simultaneous use with iodine is not recommended. It should also not be used together with soap or products containing an anionic group (for example, saponins or sodium lauryl sulfate). Before use, it is important to thoroughly rinse off any soap residue, as it may inactivate the effect of the product.

Does the drug affect the ability to drive a vehicle?

No, the drug does not affect reaction speed.

Instructions for use

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT CHLORHEXIDINE

Composition:

Active substance: chlorhexidine;

1 suppository contains 20% solution of chlorhexidine digluconate equivalent to 16 mg of chlorhexidine;

Excipient: polyethylene oxide.

Dosage form. Suppositories.

Main physicochemical properties: suppositories are white to white with a yellowish tinge; marbling is permissible. Presence of a funnel-shaped depression and an air core is allowed.

Pharmacotherapeutic group.

Antimicrobial and antiseptic agents used in gynecology. ATC code G01AX.

Pharmacological properties.

Pharmacodynamics.

Chlorhexidine digluconate exerts a rapid and pronounced effect against gram-positive and gram-negative bacteria, yeasts, and dermatophytes: Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Trichomonas vaginalis. Some strains of Pseudomonas spp. and Proteus spp. are weakly sensitive to the drug. The drug is ineffective against acid-resistant bacterial forms, bacterial spores, fungi, and viruses.

Pharmacokinetics.

When administered intravaginally, it is practically not absorbed and does not produce systemic effects.

Clinical characteristics.

Indications.

Prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) and infectious-inflammatory complications in obstetrics and gynecology (prior to surgical treatment of gynecological diseases, before delivery and abortion, before and after insertion of intrauterine contraceptive device, before and after cervical diathermocoagulation, before intrauterine examinations).

Treatment of bacterial vaginosis, colpitis, cervical erosion.

Contraindications.

Individual hypersensitivity to the components of the medicinal product.

Interaction with other medicinal products and other types of interactions.

Chlorhexidine bigluconate must not be used together with detergents containing anionic groups (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose), as well as with soap.

The presence of soap may inactivate chlorhexidine; therefore, soap residues must be thoroughly washed off before application of the medicinal product CHLORHEXIDINE. Hygiene of external genital organs does not affect the efficacy and tolerability of the pessaries, as the drug is administered intravaginally. Concomitant use with iodine is not recommended.

Special precautions for use

Contact of hypochlorite bleaching agents with fabrics previously in contact with chlorhexidine-containing medicinal products may lead to the appearance of brown stains on the fabric.

Use during pregnancy or breastfeeding

Not contraindicated.

Ability to influence reaction rate when driving or operating machinery

Has no effect.

Method of administration and dosage.

The medicinal product is intended for intravaginal use. Before administration, remove the suppository from its blister packaging.

Treatment: apply 1 suppository twice daily for 7–10 days depending on the nature of the disease. If necessary, the treatment course may be extended up to 20 days.

Prophylaxis of sexually transmitted diseases: apply a single dose of 1 suppository no later than 2 hours after sexual intercourse.

Pregnancy. Depending on the severity of the infection, bacteriological test results, and the presence of a threat of pregnancy termination, apply 1 suppository of chlorhexidine bigluconate once or twice daily as monotherapy or as part of combination therapy. Duration of use is 5 to 10 days.

During breastfeeding, the drug should be used at the usual recommended doses.

Children.

There is no experience with use in pediatric practice.

Overdose.

Overdose and toxic effects have not been observed with the use of this drug.

Side effects.

Allergic reactions, itching, burning, and irritation at the site of administration may occur.

Shelf life. 2 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 ºC. Keep out of reach of children.

Packaging. 5 suppositories per strip, 2 strips per cardboard box.

Prescription status. Over-the-counter.

Manufacturer.

LLC "FARMEKS GROUP".

Manufacturer's address and place of business.

100, Shevchenka Street, Boryspil, Kyiv region, 08301, Ukraine.

Similar drugs

The original data is available in the language of the country of manufacture.

Data source: State Register of Medicinal Products of Ukraine

Data last verified: August 13, 2026